Every grant, every vest schedule, every year. Concentration risk made explicit so the next vest decision is one informed by the whole picture, not one grant at a time.
Elevated concentration. Consider selling some vested shares and diversifying. A 30% drop in the company stock would materially affect your overall position.
After-tax estimate uses an average effective rate, not your true marginal stack. Concentration treats only unvested RSU value as company exposure; if you also hold vested company shares not yet sold, add those into the net-worth figure to capture the full picture.
Worth keeps the dashboard live against your full balance sheet and flags when your sell-at-vest policy is slipping. Join the waitlist.
Because they're already economically yours, even if not yet liquid. Your career trajectory is correlated with the company too, a bad quarter can hit comp, vest values, and job security simultaneously. The honest concentration number includes them.
A pre-committed rule to sell all (or most) RSUs as they vest, without trying to time the stock. Removes single-name concentration risk mechanically and avoids the behavioural bias of holding company stock because you 'know' it's going up. Most financial planners recommend this as the default for non-executive employees.
A rough average, your true marginal rate depends on bracket, deductions, state, NI bands, and whether you're in PAYE or estimated taxes. Treat the after-tax figure as a planning ballpark, not a tax-return number.